What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6.8% in the morning session after Barclays boosted ...

Qualcomm (NASDAQ:QCOM): Wireless chipmaker Qualcomm (NASDAQ:QCOM) fell by 4.7% on Wednesday after a leverage-driven rout in ...

TXG collaborates with the Cleveland Clinic to advance bladder cancer diagnostics using Flex Apex, Xenium and potentially ...

Key opportunities in the AI in genomics market include the increasing adoption of precision medicine, AI-driven genome ...

For the last two weeks, the headline has been a rotation out of mega-cap tech. The money split into baskets. This week, one of those baskets resolved into focus: genomics.

The era of predictive genomics is rapidly reshaping how we think about disease, risk and lifelong health. Recent advances in whole-genome sequencing have equipped clinicians with insights into our ...

Genetic testing is becoming an increasingly important component of reproductive health care. It has evolved, over the years, ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

View 10x Genomics Inc Class A TXG stock quote prices, financial information, real-time forecasts, and company news from CNN.

On June 8, 2026, Google DeepMind, Google.org, and the Wellcome Sanger Institute announced a five-year artificial intelligence ...

X Genomics (TXG) stock climbed 3.8% after revealing a Cleveland Clinic partnership for bladder cancer research using Flex ...

Bionano Genomics remains under watch as market volatility raises attention on clinical adoption, funding discipline, and diagnostics demand.